Literature DB >> 26506919

Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes.

Koichi Nisijima1.   

Abstract

Serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS) are life-threatening adverse reactions caused by serotonergic antidepressants and neuroleptics, respectively. SS and NMS have overlapping clinical features, and thus differentially diagnosing the syndromes can be difficult in patients who are taking both types of drugs. Here, the author reports a unique case of a patient who developed SS that overlapped with NMS after taking imipramine and lithium carbonate with the subsequent addition of metoclopramide. This is the first case report of SS that overlapped with NMS. The author also briefly summarizes the clinical symptoms of each syndrome and describes the approaches that were used to differentially diagnose the two syndromes.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Imipramine; Lithium carbonate; Metoclopramide; Neuroleptic malignant syndrome; Serotonin syndrome

Mesh:

Substances:

Year:  2015        PMID: 26506919     DOI: 10.1016/j.ajp.2015.10.003

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  3 in total

1.  Perioperative Considerations for Patients With Major Depressive Disorder Undergoing Surgery.

Authors:  Edwin N Aroke; Alexis N Robinson; Bryan A Wilbanks
Journal:  J Perianesth Nurs       Date:  2020-01-16       Impact factor: 1.084

2.  Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission.

Authors:  Faizan Mazhar; Shahzad Akram; Nafis Haider; Rafeeque Ahmed
Journal:  Case Rep Med       Date:  2016-06-28

3.  Metoclopramide-induced Serotonin Syndrome.

Authors:  Sreenath Meegada; Rajiv Prakash Heda; Sanjaya Satapathy; Rajanshu Verma
Journal:  Cureus       Date:  2019-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.